Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Sorrento Therapeutics a Good Coronavirus Stock to Buy?


What do investors like to see after a stock doubles? How about another double? That's exactly what Sorrento Therapeutics (NASDAQ: SRNE) stock has done. It soared a little over 100% in 2020 and has doubled yet again so far in 2021.

Excitement about the biotech's COVID-19 programs has fueled this fantastic performance. But is Sorrento a good coronavirus stock to buy now?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments